James M. Haughian, Ph.D. - Publications

Affiliations: 
2008 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Molecular Biology, Oncology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Ogba N, Manning NG, Bliesner BS, Ambler SK, Haughian JM, Pinto MP, Jedlicka P, Joensuu K, Heikkilä P, Horwitz KB. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells. Breast Cancer Research : Bcr. 16: 489. PMID 25475897 DOI: 10.1186/s13058-014-0489-4  0.72
2014 Knox AJ, Scaling AL, Pinto MP, Bliesner BS, Haughian JM, Abdel-Hafiz HA, Horwitz KB. Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease. Breast Cancer Research : Bcr. 16: 418. PMID 25116921 DOI: 10.1186/s13058-014-0418-6  0.72
2012 Haughian JM, Pinto MP, Harrell JC, Bliesner BS, Joensuu KM, Dye WW, Sartorius CA, Tan AC, Heikkilä P, Perou CM, Horwitz KB. Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch. Proceedings of the National Academy of Sciences of the United States of America. 109: 2742-7. PMID 21969591 DOI: 10.1073/pnas.1106509108  0.72
2011 Luo W, Gumen A, Haughian JM, Wiltbank MC. The role of luteinizing hormone in regulating gene expression during selection of a dominant follicle in cattle. Biology of Reproduction. 84: 369-78. PMID 20962252 DOI: 10.1095/biolreprod.110.085274  0.72
2011 Kabos P, Haughian JM, Wang X, Dye WW, Finlayson C, Elias A, Horwitz KB, Sartorius CA. Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers. Breast Cancer Research and Treatment. 128: 45-55. PMID 20665103 DOI: 10.1007/s10549-010-1078-6  0.72
2009 Haughian JM, Reno EM, Thorne AM, Bradford AP. Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis. International Journal of Cancer. Journal International Du Cancer. 125: 2556-64. PMID 19672862 DOI: 10.1002/ijc.24633  0.72
2009 Reno EM, Haughian JM, Jackson TA, Thorne AM, Bradford AP. c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells. Apoptosis : An International Journal On Programmed Cell Death. 14: 809-20. PMID 19424800 DOI: 10.1007/s10495-009-0354-6  0.72
2009 Haughian JM, Bradford AP. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells. Journal of Cellular Physiology. 220: 112-8. PMID 19235902 DOI: 10.1002/jcp.21741  0.72
2008 Reno EM, Haughian JM, Dimitrova IK, Jackson TA, Shroyer KR, Bradford AP. Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors. Human Pathology. 39: 21-9. PMID 17959229 DOI: 10.1016/j.humpath.2007.05.023  0.72
2006 Haughian JM, Jackson TA, Koterwas DM, Bradford AP. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta. Endocrine-Related Cancer. 13: 1251-67. PMID 17158769 DOI: 10.1677/erc.1.01278  0.72
2003 Navratil AM, Bliss SP, Berghorn KA, Haughian JM, Farmerie TA, Graham JK, Clay CM, Roberson MS. Constitutive localization of the gonadotropin-releasing hormone (GnRH) receptor to low density membrane microdomains is necessary for GnRH signaling to ERK. The Journal of Biological Chemistry. 278: 31593-602. PMID 12791688 DOI: 10.1074/jbc.M304273200  0.72
Show low-probability matches.